News|Events|January 9, 2025
OPT Congress: Oligonucleotide & mRNA Therapeutics: March 11–12, 2025
Author(s)BioPharm International Editors
This event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists, and technology providers to discuss advances in next-generation therapeutics.
Dates: March 11–12, 2025
Location: Seaport Hotel, Boston, Mass. & Virtual
Description: This event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists, and technology providers to discuss advances in next-generation therapeutics.
Registration:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5